Feasibility of a Digital Storytelling Intervention for Hematopoietic Cell Transplant Patients

2021 ◽  
Author(s):  
Wonsun (Sunny) Kim ◽  
Shelby Langer ◽  
Michael Todd ◽  
Linda Larkey ◽  
Soojung Jo ◽  
...  
Keyword(s):  
Digital Storytelling ◽  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Hematopoietic Cell Transplant ◽  
Transplant Patients

scholarly journals Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

2021 ◽  
Author(s):  
Riad El Fakih ◽  
Alfadil Haroon ◽  
Feras Alfraih ◽  
Murtadha K. Al-Khabori ◽  
Mohsen Alzahrani ◽  
...  
Keyword(s):  
Middle East ◽  
Clinical Course ◽  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Hematopoietic Cell Transplant ◽  
Transplant Patients

Outcomes of pediatric oncology and hematopoietic cell transplant patients receiving extracorporeal membrane oxygenation

Perfusion ◽  
2019 ◽  
Vol 34 (7) ◽  
pp. 598-604
Author(s):  
Danielle K Maue ◽  
Michael J Hobson ◽  
Matthew L Friedman ◽  
Elizabeth AS Moser ◽  
Courtney M Rowan
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Extracorporeal Membrane Oxygenation ◽  
Pediatric Intensive Care Unit ◽  
Pediatric Intensive Care ◽  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Hematopoietic Cell Transplant ◽  
Membrane Oxygenation ◽  
Transplant Patients

Background/objectives: There is controversy regarding the utilization of extracorporeal membrane oxygenation in pediatric patients with an underlying oncologic diagnosis or who have undergone hematopoietic cell transplant. We hypothesized that these patients have higher mortality, more bleeding complications, more blood product utilization, and a higher rate of new infections than the general pediatric intensive care unit population supported with extracorporeal membrane oxygenation. Design/methods: This is a retrospective chart review at a single center quaternary care pediatric hospital including all pediatric intensive care unit extracorporeal membrane oxygenation patients from 2011 to 2016. Patients were categorized as either oncology/hematopoietic cell transplant or general pediatric intensive care unit. Patients from the cardiovascular intensive care unit or the neonatal intensive care unit were excluded. Results: A total of 38 patients met inclusion criteria of which 7 were oncology/hematopoietic cell transplant patients. The oncology/hematopoietic cell transplant group had lower platelets at the start of extracorporeal membrane oxygenation (p = 0.02) but other pre-extracorporeal membrane oxygenation characteristics were similar. Extracorporeal membrane oxygenation survival was lower in the oncology/hematopoietic cell transplant group (29% vs 77%, p = 0.02). The incidence of bleeding complications and new infections did not differ. The oncology/hematopoietic cell transplant group received more platelets (median of 15.9 mL/kg/day (interquartile range 8.4, 36.6) vs 7.9 mL/kg/day (3.3, 21.9), p = 0.04) and fresh frozen plasma (14.0 mL/kg/day (3, 15.7) vs 1.8 mL/kg/day (0.5, 5.9), p = 0.04). Conclusion: Oncology and hematopoietic cell transplant patients had a higher mortality and received more blood products while on extracorporeal membrane oxygenation than the general pediatric intensive care unit patients despite similar pre-extracorporeal membrane oxygenation characteristics. Physicians should use caution when deciding whether or not to utilize extracorporeal membrane oxygenation in this population.

scholarly journals How We Treat Fever and Hypotension in Pediatric Hematopoietic Cell Transplant Patients

2020 ◽  
Vol 10 ◽  
Author(s):  
Matt S. Zinter ◽  
Christopher C. Dvorak ◽  
Jeffery J. Auletta
Keyword(s):  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Hematopoietic Cell Transplant ◽  
Transplant Patients

Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers

2019 ◽  
Vol 35 (4) ◽  
pp. 651-660
Author(s):  
Jackie Foster ◽  
Heather Moore ◽  
Jaime M. Preussler ◽  
Linda J. Burns ◽  
Jenna Hullerman Umar ◽  
...  
Keyword(s):  
Decision Making ◽  
Information Needs ◽  
Treatment Decision ◽  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Hematopoietic Cell Transplant ◽  
Treatment Decision Making ◽  
Transplant Patients
Sign in / Sign up

Export Citation Format

Share Document